Healthpeak Properties, Inc.
NYSE:PEAK
17.1 (USD) • At close March 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,181.003 | 526.635 | 457.699 | 437.505 | 415.281 | 422.551 | 343.584 | 241.034 | 129.441 | 53.334 | 16.799 | 12.947 | 13.847 |
| Cost of Revenue
| 902.06 | 171.1 | 137.408 | 128.198 | 124.819 | 122.62 | 97.035 | 65.999 | 31.026 | 10.154 | 4.65 | 4.758 | 4.953 |
| Gross Profit
| 1,278.943 | 355.535 | 320.291 | 309.307 | 290.462 | 299.931 | 246.549 | 175.035 | 98.415 | 43.18 | 12.149 | 8.189 | 8.894 |
| Gross Profit Ratio
| 0.586 | 0.675 | 0.7 | 0.707 | 0.699 | 0.71 | 0.718 | 0.726 | 0.76 | 0.81 | 0.723 | 0.633 | 0.642 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 95.132 | 40.209 | 37.757 | 33.763 | 33.099 | 28.816 | 22.957 | 18.397 | 14.908 | 11.44 | 3.689 | 1.313 | 1.252 |
| Selling & Marketing Expenses
| 8 | 7.9 | 8 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 95.132 | 40.209 | 37.757 | 33.763 | 33.099 | 28.816 | 22.957 | 18.397 | 14.908 | 11.44 | 3.689 | 1.313 | 1.252 |
| Other Expenses
| 6.808 | 189.641 | 157.87 | 149.59 | 146.436 | 158.389 | 125.159 | 86.589 | 45.471 | 16.731 | 5.107 | 4.15 | 4.588 |
| Operating Expenses
| 845.033 | 229.85 | 195.627 | 183.353 | 179.535 | 187.205 | 148.116 | 104.986 | 60.379 | 28.171 | 8.796 | 5.462 | 5.84 |
| Operating Income
| 360.802 | 124.895 | 123.094 | 124.697 | 110.899 | 112.726 | 98.433 | 70.049 | 38.036 | 15.009 | 1.413 | 1.563 | 1.617 |
| Operating Income Ratio
| 0.165 | 0.237 | 0.269 | 0.285 | 0.267 | 0.267 | 0.286 | 0.291 | 0.294 | 0.281 | 0.084 | 0.121 | 0.117 |
| Total Other Income Expenses Net
| 81.357 | -14.859 | -36.311 | -56.209 | -33.713 | 11.778 | -11.652 | -14.663 | -14.659 | -12.52 | -1.694 | -1.042 | -1.762 |
| Income Before Tax
| 314.936 | 110.036 | 86.783 | 68.488 | 77.186 | 58.321 | 39.773 | 31.522 | 12.741 | -4.418 | -2.636 | -2.853 | -3.325 |
| Income Before Tax Ratio
| 0.144 | 0.209 | 0.19 | 0.157 | 0.186 | 0.138 | 0.116 | 0.131 | 0.098 | -0.083 | -0.157 | -0.22 | -0.24 |
| Income Tax Expense
| -9.617 | 72.234 | 61.384 | 58.293 | 67.697 | 11.778 | 48.818 | 25.52 | 11.693 | 6.621 | 5.59 | 3.34 | 6.114 |
| Net Income
| 306.009 | 37.802 | 25.399 | 10.195 | 9.489 | 56.23 | 38.146 | 29.981 | 11.788 | -4.037 | -2.237 | -1.656 | -3.06 |
| Net Income Ratio
| 0.14 | 0.072 | 0.055 | 0.023 | 0.023 | 0.133 | 0.111 | 0.124 | 0.091 | -0.076 | -0.133 | -0.128 | -0.221 |
| EPS
| 0.56 | 0.07 | 0.047 | 0.019 | 0.02 | 0.31 | 0.23 | 0.22 | 0.15 | -0.12 | -0.13 | -0.14 | -0.29 |
| EPS Diluted
| 0.56 | 0.07 | 0.047 | 0.019 | 0.019 | 0.3 | 0.23 | 0.22 | 0.15 | -0.12 | -0.13 | -0.14 | -0.29 |
| EBITDA
| 1,190.619 | 314.536 | 280.964 | 274.287 | 257.335 | 271.229 | 223.775 | 156.753 | 83.611 | 31.835 | 10.154 | 7.156 | 9.599 |
| EBITDA Ratio
| 0.546 | 0.597 | 0.614 | 0.627 | 0.62 | 0.642 | 0.651 | 0.65 | 0.646 | 0.597 | 0.604 | 0.553 | 0.693 |